Advances novel therapies which target female reproductive biology to improve fertility and manage gynecologic disorders.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Celmatix builds therapeutics aimed at addressing women’s reproductive health by leveraging deep biological insights and molecular innovation. Its work focuses on creating treatments that modulate ovarian function, infertility, and inflammation-driven gynecological conditions to shift toward disease-modifying interventions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Celmatix Management Team
Investors
Topspin Partners LP
Celmatix Valuations & Financials
View real-time NPM data on Celmatix stock including daily Celmatix stock price estimates, valuation history, and historical share price information. Access Celmatix financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Celmatix pricing across six independent market signals. Looking for private company due diligence data sources on Celmatix? Get in touch to learn more.
Similar Companies
like Celmatix
restor3d
Healthcare & Life Sciences
Creating implants that adapt to patient anatomy through AI-driven three dimensional printing for more precise and effective surgical outcomes.
Humolyte
Healthcare & Life Sciences
Blends electrolytes with an HMO prebiotic for gut-aware hydration that supports mucosal health and fluid retention.
TippingPoint Biosciences
Healthcare & Life Sciences
Novel drug discovery platform targeting dysfunctional DNA packaging to treat cancer and neurodegenerative diseases without affecting healthy cells.
Cognoa
Healthcare & Life Sciences
Provides AI-enabled screening and care tools for early developmental and behavioral challenges.
SPARK Neuro
Healthcare & Life Sciences
Analyzes brain and biometric data to deliver objective cognitive and engagement insights for research and clinical use.
ILiAD Biotechnologies
Healthcare & Life Sciences
Clinical stage biotech company developing advanced vaccines to prevent and treat Bordetella pertussis-related diseases.
KODE Health
Healthcare & Life Sciences
Health-tech platform connecting hospitals with medical coders in real-time, using AI to optimize healthcare revenue cycles.
ReAlta Life Sciences
Healthcare & Life Sciences
Develops rebalanced immune responses and inflammatory pathways to treat serious diseases with limited therapeutic options.
Aware Health
Healthcare & Life Sciences
Connects employers’ workers with tele-rehab, pain science, and exercise therapy to avoid surgery and speed recovery.
FAQ
We have answers
Celmatix stock does not trade on public stock exchanges. Celmatix stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Celmatix stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Celmatix Stock does not trade on public stock exchanges. In order to sell Celmatix shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Celmatix does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Celmatix share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Celmatix stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Celmatix stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Celmatix stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Celmatix is a private company and has not had an IPO. There is currently no Celmatix IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Celmatix IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
